ArticleScientific reports2026
LncPVT1 modulates decidualization and links to recurrent spontaneous abortions via glucose and lipid metabolic regulation.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Recurrent spontaneous abortion (RSA), defined by the occurrence of two or more consecutive pregnancy losses, significantly affects women’s quality of life. However, the intricate and complex mechanisms still pose bottlenecks in the diagnosis and treatment of RSA. Transcriptome analysis of decidual tissue, along with pathway analysis of differentially expressed genes, revealed that the most significant differences were observed in pathways related to linoleic acid metabolism, glycolysis/gluconeogenesis, glycerophospholipid metabolism, and arachidonic acid metabolism, all of which are integral to glucose and lipid metabolism. Through upstream mechanistic studies, it has been found that long non-coding plasmacytoma variant translocation 1 (lncPVT1) plays a crucial regulatory role in modulating these pathways. The present study aimed to verify the hypothesis that lncPVT1 modulates the biological functions of decidual tissue in RSA and to investigate the upstream mechanism involved. It was found that lncPVT1 was overexpressed in individuals with RSA. Furthermore, knockdown of lncPVT1 enhanced the proliferation, migration, and invasion of human endometrial stromal cells while decreasing apoptosis. In vitro experiments demonstrated that lncPVT1 knockdown influences the expression of key enzymes in the glycolytic pathway, including glucose transporter 1 (Glut1), glucose transporter 4 (Glut4), hexokinase 2 (HK2), and lactate dehydrogenase A (LDHA), as well as the expression of TNF receptor-associated factor 6 (TRAF6) in the lipid metabolism and RSA. Overall, our study demonstrated that lncPVT1 knockdown disrupts glycolysis and lipid metabolism, subsequently impacting the incidence of RSA. This study provides novel insights into understanding the molecular pathogenesis of RSA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.